Eli Lilly has launched new single-dose 2.5mg and 5.0mg vials of its obesity drug Zepbound in a move that ... via the company's LillyDirect direct-to-consumer self-pay channel – are "at least ...

Telehealth company Ro will offer single-dose vials ... to Lilly's recently launched LillyDirect direct-to-consumer (DTC) platform that will be able to offer the lower-cost version of Zepbound ...

Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q4 2024 Earnings Call ... the uptake of single-uses Zepbound vials increased. We had no wholesaler backorders as we ...

With its weight-loss fetish and direct-to-consumer marketing ... Indiana-based Eli Lilly rolled out its own GLP-1 drugs, Mounjaro and Zepbound. With an American company invading Novo’s market ...

In contrast to regular direct-to-consumer ... And in the case of Zepbound, patients can purchase the drug directly from the manufacturer, Eli Lilly, at a price that is well below the list price.

SAN FRANCISCO — When Eli Lilly last year started offering lower-priced vials of its blockbuster obesity drug Zepbound, which were previously sold in injectable pens, it framed the move as a way ...

Eli Lilly also states that vial forms are cheaper than the auto-injector pre-filled pens. It also means you will be better protected against buying counterfeit or compounded Zepbound. Zepbound in ...